Case Study: Enabling Regulatory‑Ready Bioanalysis Through Robust Assay Development
1 June 2026
Overview
A UK-based specialty pharma company required a fit‑for‑purpose biochemical assay for their regulatory non-clinical safety study. Our bioanalysis experts were able to rapidly develop and optimise a tailored assay for reliable non‑haem iron quantification in tissues. This assay supported one of the pivotal objectives for a regulatory non-clinical safety study.
Request to download a copy of case study: Enabling Regulatory‑Ready Bioanalysis Through Robust Assay Development today.